Exclusive-China invites global investors for rare meeting as economy sputters-sources

By Xie Yu and Julie Zhu HONG KONG (Reuters) – China’s financial regulators have invited some of the world’s biggest investors to a rare symposium next week, three sources said, seeking to encourage foreigners to keep investing in the world’s second-largest economy despite its recent weakness and rising geopolitical tensions. The meeting in Beijing next…

Read More

China central bank to use tools such as RRR to tackle economic woes

By Kevin Yao BEIJING (Reuters) -China’s central bank will use policy tools such as the reserve requirement ratio (RRR) and medium-term lending facility to weather the challenges facing the world’s second-largest economy, a senior bank official said on Friday. Momentum in China’s post-pandemic recovery has slowed sharply after a brisk pickup in the first quarter,…

Read More

Italy’s luxury groups set aside rivalries to keep it local

By Elisa Anzolin MILAN (Reuters) – Italy’s luxury fashion groups, which for decades jealously guarded their independence, have started teaming up to protect their supply chains and the Italian roots of smaller companies, showing a new spirit of collaboration. Control of the supply chain has become increasingly important for luxury brands, ensuring products get to…

Read More

Analysis-BOJ in a bind as price pressures heighten case for early policy tweak

By Leika Kihara TOKYO (Reuters) – The Bank of Japan is caught in a dilemma with growing prospects of sustained inflation heightening the case for an early tweak to its yield control policy, despite Governor Kazuo Ueda’s reassurances he would “patiently” maintain massive stimulus. The first test will come at the central bank’s policy meeting…

Read More

Analysis-Tumbling US dollar a boon to risk assets across the globe

By Saqib Iqbal Ahmed NEW YORK (Reuters) – Cooling U.S. inflation is accelerating a decline in the dollar, and risk assets around the world stand to benefit. The dollar is down nearly 13% against a basket of currencies from last year’s two-decade high and stands at its lowest level in 15 months. Its decline quickened…

Read More

Strong U.S. demand eases pressure on Novo to show weight-loss drug’s health benefits

By Maggie Fick LONDON (Reuters) – Soaring U.S. demand for Novo Nordisk’s weight-loss drug has reduced the pressure from investors on the company to deliver strong results in its trial to test whether the drug also has medical benefits, eight investors and analysts say. Novo is expected to publish in August the results of a…

Read More